Linkedin
Sign in
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Type here...
Search
Home
About
Editor’s Corner
Contribute
Contact Us
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
Solutions & Pricing
Partner
Instagram
Linkedin
Twitter
Subscribe
Subscribe
Thursday, April 2, 2026
27.6
C
Bengaluru
Home
About
Editor’s Corner
Contribute
Contact Us
My account
Get into your account.
Login
Register
type here...
Search
Facebook
Linkedin
Twitter
Youtube
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Hot topics
Soft Power and the Physician
0
GST Special Issue carrying an interview with Sunil Attavar - CMD, Group Pharma and President, Karnataka Drugs and Pharmaceuticals Manufacturers Association (KDPMA)
Pharma Marketing & The Reinvention
0
Introducing the top 10 companies in top 10 therapy areas according to statistics published by AIOCD
Sales Readiness For Trainers and Reps – Improve Effectiveness In A New Pharma World
0
Last week, I was in a meeting with the...
India’s Patent Revocations: Strengthening Access and Challenging Evergreening
0
The Indian Patent Office’s recent decision to revoke Novartis’...
Indian Pharma October 2025 Sales Data
0
1. Overall Market Growth & Trends (IPM Key Highlights): Robust...
Facebook
Linkedin
Twitter
Youtube
Healthcare Trends
Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?
0
The "aspirinization" of obesity—moving from a niche, high-cost injectable...
IPM February 2026: Market Intelligence Report
0
Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...
FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare
0
When drones first appeared on battlefields, military establishments reacted...
Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality
0
Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...
Healthcare and Gulf War: When Elephants Fight, the Grass Gets Trampled
0
From Gas Cylinders to ICU Beds: How the Gulf...
Marketing
Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?
0
The "aspirinization" of obesity—moving from a niche, high-cost injectable...
IPM February 2026: Market Intelligence Report
0
Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...
FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare
0
When drones first appeared on battlefields, military establishments reacted...
Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality
0
Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...
Healthcare and Gulf War: When Elephants Fight, the Grass Gets Trampled
0
From Gas Cylinders to ICU Beds: How the Gulf...
Policies/Sales
Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?
0
The "aspirinization" of obesity—moving from a niche, high-cost injectable...
IPM February 2026: Market Intelligence Report
0
Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...
FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare
0
When drones first appeared on battlefields, military establishments reacted...
Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality
0
Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...
Healthcare and Gulf War: When Elephants Fight, the Grass Gets Trampled
0
From Gas Cylinders to ICU Beds: How the Gulf...
Strategy
Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?
0
The "aspirinization" of obesity—moving from a niche, high-cost injectable...
IPM February 2026: Market Intelligence Report
0
Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...
FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare
0
When drones first appeared on battlefields, military establishments reacted...
Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality
0
Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...
Healthcare and Gulf War: When Elephants Fight, the Grass Gets Trampled
0
From Gas Cylinders to ICU Beds: How the Gulf...
Subscribe
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Hot topics
Digital Noise to Digital Voice – A 4-Module Workshop for Pharma People
0
https://www.youtube.com/watch?v=BOO_CNxEzwQ When Covid19 struck for the first time in March 2020, the...
Excellence or Mediocrity—What Are You Building?
0
Excellence is a choice. So is Mediocrity Excellence is a...
Novo Nordisk to Acquire Akero Therapeutics for $4.7 Billion
0
Novo Nordisk has announced plans to acquire Akero Therapeutics...
Pharma Marketing in the New Age
0
Inside this Issue 1. Conference Notes: Pharma Marketing in the New...
Cipla–Pfizer Deal: How “Ordinary” Brands Are Fueling an Extraordinary Power Shift in Indian Pharma
0
What’s really happening in the Cipla–Pfizer tie‑up At first glance,...
Facebook
Linkedin
Twitter
Youtube
Healthcare Trends
Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?
0
The "aspirinization" of obesity—moving from a niche, high-cost injectable...
IPM February 2026: Market Intelligence Report
0
Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...
FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare
0
When drones first appeared on battlefields, military establishments reacted...
Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality
0
Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...
Healthcare and Gulf War: When Elephants Fight, the Grass Gets Trampled
0
From Gas Cylinders to ICU Beds: How the Gulf...
Marketing
Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?
0
The "aspirinization" of obesity—moving from a niche, high-cost injectable...
IPM February 2026: Market Intelligence Report
0
Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...
FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare
0
When drones first appeared on battlefields, military establishments reacted...
Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality
0
Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...
Healthcare and Gulf War: When Elephants Fight, the Grass Gets Trampled
0
From Gas Cylinders to ICU Beds: How the Gulf...
Policies/Sales
Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?
0
The "aspirinization" of obesity—moving from a niche, high-cost injectable...
IPM February 2026: Market Intelligence Report
0
Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...
FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare
0
When drones first appeared on battlefields, military establishments reacted...
Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality
0
Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...
Healthcare and Gulf War: When Elephants Fight, the Grass Gets Trampled
0
From Gas Cylinders to ICU Beds: How the Gulf...
Strategy
Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?
0
The "aspirinization" of obesity—moving from a niche, high-cost injectable...
IPM February 2026: Market Intelligence Report
0
Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...
FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare
0
When drones first appeared on battlefields, military establishments reacted...
Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality
0
Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...
Healthcare and Gulf War: When Elephants Fight, the Grass Gets Trampled
0
From Gas Cylinders to ICU Beds: How the Gulf...
Subscribe
Screenshot-199